SCHEMBL6986320

SCHEMBL6986320

Nc1nc(N)nc(-c2ccc(NS(=O)(=O)c3cccc4ccccc34)cc2)n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.60
PGR P06401 1/20 0.56
PTPN2 P17706 3/20 0.55
PTPN1 P18031 3/20 0.55
PTPN5 P54829 3/20 0.55
SGK1 O00141 4/20 0.54
RORA P35398 1/20 0.52
RORC P51449 1/20 0.52
NR1H2 P55055 1/20 0.52
NR1H4 Q96RI1 1/20 0.52
HDAC1 Q13547 2/20 0.50
ALDH1A1 P00352 1/20 0.48
HTT P42858 1/20 0.48
PFKFB3 Q16875 1/20 0.48
MAPT P10636 1/20 0.46
HCRTR1 O43613 1/20 0.46
CYP17A1 P05093 1/20 0.45
TYMS P04818 1/20 0.44
EDNRB P24530 1/20 0.44
EDNRA P25101 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6983430 0.79 KEAP1 (0.61) PTPN2PTPN1PTPN5SGK1ALDH1A1
SCHEMBL812673 0.78 TSHR (0.74) TSHRPGRPTPN2PTPN1PTPN5
SCHEMBL31110643 0.78 TSHR (0.74) TSHRPGRPTPN2PTPN1PTPN5
SCHEMBL6985315 0.76 ATM (0.60) PGRPTPN2PTPN1PTPN5HDAC1
SCHEMBL9478942 0.76 TSHR (0.71) TSHRPGRPTPN2PTPN1PTPN5
SCHEMBL3261087 0.76 TSHR (0.71) TSHRPGRPTPN2PTPN1PTPN5
SCHEMBL6409546 0.76 TSHR (0.67) TSHRPGRPTPN2PTPN1PTPN5
SCHEMBL16785737 0.76 TSHR (0.67) TSHRPGRPTPN2PTPN1PTPN5
SCHEMBL15762086 0.75 TSHR (1.00) TSHRPGRRORARORCNR1H2
SCHEMBL5046687 0.74 TSHR (0.64) TSHRPGRPTPN2PTPN1PTPN5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US claimed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP claimed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO claimed
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP disclosed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO disclosed